Half Year Report 2020

Half Year Report 2020

In the first half of 2020, HAEMATO AG achieved an EBITDA of EUR 2,066 thousand. Sales amounted to EUR 115.8 million. In the first six months of the financial year 2020, HAEMATO AG, Berlin (ISIN: DE0006190705) achieved an IFRS group sales of EUR 115.8 million (previous...
Ad-hoc disclosure under Art.17 MAR

Ad-hoc disclosure under Art.17 MAR

HAEMATO AG: Ad-hoc disclosure under Article 17 MAR HAEMATO AG: MPH Health Care AG brings its shares in HAEMATO AG to M1 Kliniken AG as part of a non-cash capital increase. Today MPH Health Care AG and M1 Kliniken AG informed us that MPH Health Care AG transfers all of...
AGM postponement

AGM postponement

Due to the present imponderables HAEMATO AG will reschedule the Annual General Meeting originally intended on July 8, 2020 to a later date. Due to the current uncertainties around the COVID-19 pandemic the Executive Board and the Supervisory Board of HAEMATO AG,...